Skip to main content
. 2016 Sep 1;21(35):30332. doi: 10.2807/1560-7917.ES.2016.21.35.30332

Table 1. Hepatitis E virus RNA progression in blood donors, Germany, 2011 (n = 10).

Donor Maximum concentration
(IU/mL)
Daya with maximum concentration Maximum concentration in window period
(IU/mL)
Distance to last negative sample (days) Distance to last positive sample
(days)
Mean time between serial samples
in days (range)
Duration interval 1b (days) Duration interval 2c (days)
D1 2.63 × 104 0 5.13 × 103 43 10 5
(3–10)
20 (47)
D2 1.02 × 105 25 1.02 × 105 46 26 11
(5–26)
52 (88)
D3 1.51 × 103 0 No window period 30 8 8
(8)
1 20
D4 4.74 × 104 28 4.74 × 104 9 6 10
(6–15)
42 50
D5 1.86 × 101 0 No window period > 1 year 3 7
(3–11)
11 (195)
D6 1.63 × 104 21 1.63 × 104 7 7 7
(7)
35 42
D7 2.13 × 104 33 2.13 × 104 7 3 6
(3–12)
46 51
D8 2.19 × 105 28 2.19 × 105 28 7 6
(3–12)
52 80
D9 1.36 × 103 7 1.36 × 103 54 42 16
(3–42)
7 (55)
D10 2.48 × 103 21 2.48 × 103 129 38 21
(21)
21 (105)
Range 1.86 × 101 – 2.19 × 105 0–33 1.36 × 103 – 2.19 × 105 NC NC NC 1–52 20–80
Mean 4.38 × 104 20 5.19 × 104 NC NC NC 29 49
Median 1.88 × 104 23 1.88 × 104 NC NC NC 28 50

NC: not calculated.

a Day x post detection of HEV RNA by PCR screening.

b Duration interval 1: first positive to last positive sample.

c Duration interval 2: starting at half of the interval between the last negative and the first positive sample and ending at half of the interval between the last positive and the first negative sample. Data in parenthesis were excluded from the calculation of mean and median values because the last hepatitis E virus RNA-negative samples went back more than 30 days.